179 related articles for article (PubMed ID: 30801696)
1. HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
Grover S; MacDuffie EC; Wang Q; Bvochora-Nsingo M; Bhatia RK; Balang D; Chiyapo SP; Luckett R; Ramogola-Masire D; Dryden-Peterson SL; Lin LL; Shin SS; Zetola NM
Cancer; 2019 May; 125(10):1645-1653. PubMed ID: 30801696
[TBL] [Abstract][Full Text] [Related]
2. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965
[TBL] [Abstract][Full Text] [Related]
3. Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana.
MacDuffie E; Bvochora-Nsingo M; Chiyapo S; Balang D; Chambers A; George JM; Tuli S; Lin LL; Zetola NM; Ramogola-Masire D; Grover S
Infect Agent Cancer; 2021 Aug; 16(1):55. PubMed ID: 34344430
[TBL] [Abstract][Full Text] [Related]
4. Association Between CD4 Count and Chemoradiation Therapy Outcomes Among Cervical Cancer Patients With HIV.
Grover S; Mehta P; Wang Q; Bhatia R; Bvochora-Nsingo M; Davey S; Iyengar M; Shah S; Shin SS; Zetola NM
J Acquir Immune Defic Syndr; 2020 Oct; 85(2):201-208. PubMed ID: 32568769
[TBL] [Abstract][Full Text] [Related]
5. HIV Infection and Survival Among Women With Cervical Cancer.
Dryden-Peterson S; Bvochora-Nsingo M; Suneja G; Efstathiou JA; Grover S; Chiyapo S; Ramogola-Masire D; Kebabonye-Pusoentsi M; Clayman R; Mapes AC; Tapela N; Asmelash A; Medhin H; Viswanathan AN; Russell AH; Lin LL; Kayembe MKA; Mmalane M; Randall TC; Chabner B; Lockman S
J Clin Oncol; 2016 Nov; 34(31):3749-3757. PubMed ID: 27573661
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer.
Vendrell I; Ferreira AR; Abrunhosa-Branquinho AN; Semedo PM; Pulido CF; Jorge M; Pina MF; Pinto C; Costa L
Medicine (Baltimore); 2018 Jul; 97(30):e11592. PubMed ID: 30045290
[TBL] [Abstract][Full Text] [Related]
7. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
8. Differences in Outcomes of Chemoradiation in Women With Invasive Cervical Cancer by Human Immunodeficiency Virus Status: A Systematic Review.
Shah S; Xu M; Mehta P; Zetola NM; Grover S
Pract Radiat Oncol; 2021; 11(1):53-65. PubMed ID: 32428763
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer risk in women living with HIV across four continents: A multicohort study.
Rohner E; Bütikofer L; Schmidlin K; Sengayi M; Maskew M; Giddy J; Taghavi K; Moore RD; Goedert JJ; Gill MJ; Silverberg MJ; D'Souza G; Patel P; Castilho JL; Ross J; Sohn A; Bani-Sadr F; Taylor N; Paparizos V; Bonnet F; Verbon A; Vehreschild JJ; Post FA; Sabin C; Mocroft A; Dronda F; Obel N; Grabar S; Spagnuolo V; Quiros-Roldan E; Mussini C; Miro JM; Meyer L; Hasse B; Konopnicki D; Roca B; Barger D; Clifford GM; Franceschi S; Egger M; Bohlius J
Int J Cancer; 2020 Feb; 146(3):601-609. PubMed ID: 31215037
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R
Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
[TBL] [Abstract][Full Text] [Related]
11. Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020.
Grover S; George J; Tuli S; Lichter K; Bhatia R; Monare B; Chinniah G; Bazzett-Matabele L; Bvochora-Nsingo M; Chiyapo S; Balang D; Ralefala T; Vuylsteke P; Luckett R; Shin S; Zetola N; Ramogola-Masire D
Gynecol Oncol Rep; 2022 Dec; 44():101094. PubMed ID: 36337265
[TBL] [Abstract][Full Text] [Related]
12. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana.
Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R
BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863
[TBL] [Abstract][Full Text] [Related]
13. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE CERVICAL CANCER IN KENYA.
Gichangi P; Gathece L; Estambale B; Temmerman M
East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the effects of mEHT on the treatment-related toxicity and quality of life of HIV-positive cervical cancer patients.
Minnaar CA; Kotzen JA; Naidoo T; Tunmer M; Sharma V; Vangu MD; Baeyens A
Int J Hyperthermia; 2020; 37(1):263-272. PubMed ID: 32180481
[No Abstract] [Full Text] [Related]
15. Advanced HIV disease in the Botswana combination prevention project: prevalence, risk factors, and outcomes.
Lebelonyane R; Mills LA; Mogorosi C; Ussery F; Marukutira T; Theu J; Kapanda M; Matambo S; Block L; Raizes E; Makhema J; Lockman S; Bachanas P; Moore J; Jarvis JN
AIDS; 2020 Dec; 34(15):2223-2230. PubMed ID: 32694412
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with CD4 + cell count recovery among males and females with advanced HIV disease.
Kouamou V; Gundidza P; Ndhlovu CE; Makadzange AT;
AIDS; 2023 Dec; 37(15):2311-2318. PubMed ID: 37598355
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
Grover S; Ning MS; Bale M; Lichter KE; Shah S; Bvochora-Nsingo M; Chiyapo S; Balang D; McGinnis GJ; Ralefala T; Moloi T; Luckett R; Ramogola-Masire D; Robertson ES; Zetola NM
Int J Gynecol Cancer; 2021 Sep; 31(9):1220-1227. PubMed ID: 34312220
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium.
Einstein MH; Ndlovu N; Lee J; Stier EA; Kotzen J; Garg M; Whitney K; Lensing SY; Tunmer M; Kadzatsa W; Palefsky J; Krown SE
Gynecol Oncol; 2019 Apr; 153(1):20-25. PubMed ID: 30773222
[TBL] [Abstract][Full Text] [Related]
19. Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV.
Friebel-Klingner TM; Bazzett-Matabele L; Ramogola-Masire D; Monare B; Ralefala TB; Seiphetlheng A; Ramontshonyana G; Vuylsteke P; Mitra N; Wiebe DJ; Rebbeck TR; McCarthy AM; Grover S
JCO Glob Oncol; 2022 Nov; 8():e2200183. PubMed ID: 36395437
[TBL] [Abstract][Full Text] [Related]
20. Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
Meghani K; Puri P; Bazzett-Matabele L; Vuylsteke P; Luckett R; Monare B; Chiyapo S; Ketlametswe R; Ralefala TB; Bvochora-Nsingo M; Zetola N; Ramogola-Masire D; Grover S
Cancer; 2024 Mar; ():. PubMed ID: 38529676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
